Soligenix
SNGX
#10223
Rank
HK$0.12 B
Marketcap
HK$12.53
Share price
-1.23%
Change (1 day)
-49.67%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : HK$2.99 Million

According to Soligenix's latest financial reports the company's total debt is HK$2.99 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$11.52 M-57.77%
2023-12-31HK$27.29 M-65.89%
2022-12-31HK$80 M3%
2021-12-31HK$77.68 M-4.62%
2020-12-31HK$81.44 M8119.91%
2019-12-31HK$0.99 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31HK$2.26 M-92.28%
2014-12-31HK$29.39 M-54.23%
2013-12-31HK$64.21 M
2004-12-31HK$0.9 M-67.63%
2003-12-31HK$2.78 M-51.11%
2002-12-31HK$5.69 M236.67%
2001-12-31HK$1.69 M-32.87%
2000-12-31HK$2.51 M-17.34%
1999-12-31HK$3.04 M-1.67%
1998-12-31HK$3.09 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$5.16 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$198.75 B 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$473.67 B 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.49 B 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$0.14 B 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.90 B 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel